創新藥物
創新藥板塊聚焦原創藥物從靶點發現到臨床轉化與商業化全鏈條。核心賽道涵蓋小分子、單抗/雙抗與ADC、細胞與基因治療、核酸藥物及CRO/CMO。該板塊總市值為 1802.61 billion HKD，24h 漲跌幅 -0.20%，40 檔中，18 檔上漲 (45.00%)，19 檔下跌 (47.50%)。領漲個股為 樂普生物－Ｂ (02157)，24h 漲幅為 +6.75%。漲跌家數參差，板塊回落，但龍頭股表現相對優異。保持選擇性：圍繞臨床或政策催化事件操作；偏好現金充裕、處於後期臨床階段的研發管線，並在走弱時逢低加碼，因利率與給付/報銷訊號將影響估值。
名稱 | 最新價 | 漲跌幅 | 最新價 / 漲跌幅 | 走勢圖 | 價格區間 | 操作 |
|---|---|---|---|---|---|---|
 金斯瑞生物科技01548 | HK$16.80$69.25 | -0.11%-$0.08 | HK$16.80 -0.11% | $66.37$69.34 | ||
 石藥集團01093 | HK$8.59$35.41 | +3.49%+$1.19 | HK$8.59 +3.49% | $34.17$35.41 | ||
 康諾亞－Ｂ02162 | HK$76.65$315.98 | -6.86%-$23.29 | HK$76.65 -6.86% | $315.98$343.40 | ||
 百濟神州06160 | HK$198.3$817.4 | -0.70%-$5.7 | HK$198.3 -0.70% | $815.4$826.1 | ||
 信達生物－Ｂ01801 | HK$88.35$364.22 | -1.11%-$4.12 | HK$88.35 -1.11% | $364.22$371.84 | ||
 藥明康德02359 | HK$156.7$645.9 | -0.19%-$1.2 | HK$156.7 -0.19% | $644.7$658.7 | ||
 藥明生物02269 | HK$38.48$158.63 | -0.46%-$0.74 | HK$38.48 -0.46% | $158.63$163.49 | ||
 康方生物09926 | HK$97.35$401.32 | -1.26%-$5.15 | HK$97.35 -1.26% | $401.32$411.01 | ||
 晶泰控股02228 | HK$7.02$28.93 | -2.09%-$0.61 | HK$7.02 -2.09% | $28.61$29.97 | ||
 三生製藥01530 | HK$17.13$70.61 | 0.00%$0.00 | HK$17.13 0.00% | $69.83$71.23 | ||
 樂普生物－Ｂ02157 | HK$4.77$19.66 | +7.43%+$1.36 | HK$4.77 +7.43% | $18.01$19.66 | ||
 中國生物製藥01177 | HK$5.06$20.85 | -0.58%-$0.12 | HK$5.06 -0.58% | $20.85$21.23 | ||
 翰森製藥03692 | HK$32.60$134.39 | +0.92%+$1.23 | HK$32.60 +0.92% | $132.16$134.39 | ||
 榮昌生物09995 | HK$84.70$349.17 | -1.10%-$3.91 | HK$84.70 -1.10% | $342.99$355.56 | ||
 藥明合聯02268 | HK$53.35$219.93 | -1.83%-$4.12 | HK$53.35 -1.83% | $219.52$232.09 | ||
 康哲藥業00867 | HK$12.07$49.75 | +0.41%+$0.20 | HK$12.07 +0.41% | $49.55$50.12 | ||
 恒瑞醫藥01276 | HK$57.45$236.83 | +0.70%+$1.64 | HK$57.45 +0.70% | $233.53$237.45 | ||
 科倫博泰生物－Ｂ06990 | HK$509.0$2,098.3 | -0.87%-$18.5 | HK$509.0 -0.87% | $2,090.1$2,143.6 | ||
 四環醫藥00460 | HK$0.93$3.83 | -1.06%-$0.04 | HK$0.93 -1.06% | $3.62$3.91 | ||
 巨子生物02367 | HK$29.56$121.86 | +1.79%+$2.14 | HK$29.56 +1.79% | $119.13$121.86 |